InsiderClue
Insiders · Profile

Nussbaum Ran

Director at LB PHARMACEUTICALS · Director at Eloxx Pharmaceuticals · Director at Keros Therapeutics. Filing since 21 Mar 2018. CIK 0001609805

LBRX LB PHARMACEUTICALS INC Director · 1 trade ELOX Eloxx Pharmaceuticals, Inc. Director · 5 trades KROS Keros Therapeutics, Inc. Director · 2 trades
Company
Date
Role
Action
Shares
Amount
Of holding
LBRX LB PHARMACEUTICALS INC
12 Sep 2025
Director
Bought
1,000,000
$15.00M
243%
ELOX Eloxx Pharmaceuticals, Inc.
13 May 2021
Director
Bought
5,925,925
$8.00M
opened
KROS Keros Therapeutics, Inc.
17 Nov 2020
Director
Bought
60,000
$3.00M
2.7%
KROS Keros Therapeutics, Inc.
13 Apr 2020
Director
Bought
437,499
$7.00M
24.0%
ELOX Eloxx Pharmaceuticals, Inc.
24 Jun 2019
Director
Bought
200,000
$1.80M
23.5%
ELOX Eloxx Pharmaceuticals, Inc.
30 Apr 2018
Director
Bought
350,000
$3.41M
57.1%
ELOX Eloxx Pharmaceuticals, Inc.
22 Mar 2018
Director
Bought
6,000
$48.00K
0.8%
ELOX Eloxx Pharmaceuticals, Inc.
21 Mar 2018
Director
Bought
6,600
$49.83K
0.8%
8 decisions on file.